- Home
- PBT vs KURA Comparison
PBT vs KURA Comparison
Compare PBT & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- KURA
- Stock Information
- Founded
- PBT 1980
- KURA 2014
- Country
- PBT United States
- KURA United States
- Employees
- PBT N/A
- KURA N/A
- Industry
- PBT Oil & Gas Production
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBT Energy
- KURA Health Care
- Exchange
- PBT Nasdaq
- KURA Nasdaq
- Market Cap
- PBT 835.7M
- KURA 713.5M
- IPO Year
- PBT N/A
- KURA N/A
- Fundamental
- Price
- PBT $18.49
- KURA $8.35
- Analyst Decision
- PBT
- KURA Buy
- Analyst Count
- PBT 0
- KURA 14
- Target Price
- PBT N/A
- KURA $24.45
- AVG Volume (30 Days)
- PBT 139.9K
- KURA 1.9M
- Earning Date
- PBT 01-01-0001
- KURA 11-06-2025
- Dividend Yield
- PBT 2.93%
- KURA N/A
- EPS Growth
- PBT N/A
- KURA N/A
- EPS
- PBT 0.35
- KURA N/A
- Revenue
- PBT $18,413,820.00
- KURA $83,279,000.00
- Revenue This Year
- PBT N/A
- KURA $60.25
- Revenue Next Year
- PBT N/A
- KURA $155.10
- P/E Ratio
- PBT $51.70
- KURA N/A
- Revenue Growth
- PBT N/A
- KURA N/A
- 52 Week Low
- PBT $8.01
- KURA $5.41
- 52 Week High
- PBT $18.80
- KURA $21.40
- Technical
- Relative Strength Index (RSI)
- PBT 69.58
- KURA 60.75
- Support Level
- PBT $17.61
- KURA $8.09
- Resistance Level
- PBT $18.80
- KURA $8.90
- Average True Range (ATR)
- PBT 0.65
- KURA 0.51
- MACD
- PBT -0.01
- KURA -0.02
- Stochastic Oscillator
- PBT 87.60
- KURA 58.33
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.